STAT February 20, 2025
Adam Feuerstein

There are a number of reasons investment in the industry feels bleak right now. Here’s one

I was a bit worried last week’s angst-y rant on the bleak state of biotech investing would turn folks off. In fact, it was my most popular newsletter ever, with the version posted to STAT’s website delivering a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
Stakeholder Management and Interoperability of Biosimilars
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
FDA approves first rapid-acting insulin biosimilar for diabetes
Pharma Pulse 2/20/25: Popping the Gross-to-Net Bubble, Prompting Better Care with Question Prompt Lists & more
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal

Share This Article